CDMO Abzena is poised for massive growth with the completion of its new $60 million facility for Phase III and commercial cGMP manufacturing.
The 50,000 sqft “Lusk” facility is a welcome addition to the company’s San Diego, CA site, allowing the company to expand its services of biopharmaceuticals from initial development all the way to commercial manufacturing, while creating 125 new jobs in the area. Abzena also has facilities in Cambridge, UK and Bristol, PA.
